Clinical Research
Translational Research
Tumour Angiogenesis
Other Areas of Research
Reviews & Book Chapters
Key Presentations at national and international scientific meetings
Newsletters have moved to the new newsletters page
Obermair A, Crandon A, Perrin L, Walsh T, Carraro M, Nicklin J. Randomized Trial of skin closure after laparotomy for gynaecological surgery. Aust NZ J Surg. 2007;77:460-463.
Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment : prevalence, correlates, and supportive care needs. Cancer 2007; 109:2607-2614.
Garrett AJ, Nascimento MC, Nicklin JL, Perrin LC, Obermair A. Total laparoscopic hysterectomy: the Brisbane learning curve. Aust NZ J Obstet Gynaecol. 2007;47:65-9.
Obermair A, Fuller A, Lopez-Varela E, van Gorp T, Vergote I, Eaton L, Fowler J, Quinn M, Hammond I, Marsden D, Proietto A, Carter J, Davy M, Tripcony L, Abu-Rustum N. A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Gynecol Oncol. 2007;104:607-11.
Laky B, Janda M, Bauer J, Vavra C, Cleghorn G, Obermair A. Malnutrition among gynaecological cancer patients. Eur J Clin Nutr. 2007;61:642-6.
Janda M, Gebski V, Forder P, Jackson D, Williams G, Obermair A; LACE Trial Committee. Total laparoscopic versus open surgery for stage 1 endometrial cancer: the LACE randomized controlled trial. Contemp Clin Trials. 2006;27:353-63.
Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer. Int J Gynecol Cancer 2005; 15:319-24.
Janda M, Obermair A, Cella D, Perrin LC, Nicklin JL, Ward BG, Crandon AJ, Trimmel M. The functional assessment of cancer-vulvar: reliability and validity. Gynecol Oncol. 2005; 97:568-75.
Paramasivam S, Tripcony L, Crandon A, Quinn M, Hammond I, Marsden D, Proietto A, Davy M, Carter J, Nicklin J, Perrin L, Obermair A. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.J Clin Oncol. 2005;23:5938-42.
Neppe C, Land R, Obermair A. Wrigley forceps to deliver a bulky uterus following a total laparoscopic hysterectomy for endometrial cancer. Aust N Z J Obstet Gynaecol. 2005; 45:444-5.
Carraro Nascimento M, Diane Cominos, Davies TNJ, Obermair A. Vulval Keratoacanthoma: A Case Report. Gynecol Oncol 2005; 97:674-6.
Carraro Nascimento M, Kelley A, Martitsch C, Weidner I, Obermair A. Postoperative analgesic requirements – Total Laparoscopic Hysterectomy vs. Vaginal Hysterectomy. Aust NZ J Obstet Gynaecol 2005; 45-140-3.
Lataifeh I, Nascimento MC, Nicklin JL, Perrin LC, Crandon AJ, Obermair A. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol 2004;95:701-5.
Janda M, Obermair A, Cella D, Crandon AJ, Trimmel M. Vulvar cancer patients' quality of life: a qualitative assessment. Int J Gynecol Cancer 2004;14:875-81.
Janda M, Newman B, Obermair A, Woelfl H, Trimmel M, Schroeckmayr H, Widder J, Poetter R: Impaired quality of life in patients commencing radiotherapy for cancer. Strahlenther Onkol 2004;180:78-83.
Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ: Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol 2004;92:789-93.
McCartney AJ, Obermair A.: Total laparoscopic hysterectomy with a transvaginal tube. J Am Assoc Gynecol Laparosc 2004;11:79-82.
Petru E, Pasterk C, Reich O, Obermair A, Winter R, Breitenecker G: Small-cell carcinoma of the uterus and the vagina: experience with ten patients. Arch Gynecol Obstet 2004
Hammond IG, Obermair A, Taylor JD, Lawrence-Brown M.: The overlay autogenous tissue (OAT) patch to control major intraoperative vascular injury in an ovine model. Gynecol Oncol 2004;94:560-3.
Hammond IG, Obermair A, Taylor JD, Lawrence-Brown M: The control of severe intraoperative bleeding using an overlay autogenous tissue (OAT) patch: case reports. Gynecol Oncol 2004;94:564-6.
Janda M, Obermair A, Cella D, Crandon AJ, Trimmel M: Vulvar cancer patients' quality of life: a qualitative assessment. Int J Gynecol Cancer 2004;14:875-81.
Dittrich Ch, Sevelda P, Salzer H, Obermair A, Speiser P, Breitenecker G, Schemper M, Kaider A; Austrian Ovarian Cancer Study Group: Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin. Eur J Cancer. 2003;39:1129-40. Erratum in: Eur J Cancer 2004;40:627.
Denison U, Baumann J, Peters-Engl C, Samonigg H, Krippl P, Lang A, Obermair A, Wagner H, Sevelda P: Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 2003;79:347-53.
Nather A, Mayerhofer K, Grimm C, Hefler L, Leodolter S, Obermair A, Joura EA: Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy. Anticancer Res 2003;23:2991-4.
Obermair A, Ginbey P, McCartney AJ: Feasibility and safety of total laparoscopic radical hysterectomy. J Am Assoc Gynecol Laparosc 2003;10:345-9.
Preyer O, Obermair A, Formann E, Schmid W, Perrin LC, Ward BG, Crandon AJ, Nicklin J: The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecol Oncol 2002;86:269-73.
Obermair A, Cheuk R, Horwood K, Neudorfer M, Janda M, Nicklin JL, Perrin LC, Crandon AC: Anaemia before and during Concurrent Chemo-Radiotherapy in Patients with Cervical Carcinoma: Effect on Progression-Free Survival. Int J Gynecol Cancer 2003;13:633-9.
Preyer O, Obermair A, Formann E, Schmid W, Perrin LC, Ward PG, Nicklin JL, Crandon AJ: The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecol Oncol. 2002;86:269-273.
Clayton RD, Obermair A, Hammond IG, Leung Y, McCartney AJ: The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol 2002; 84: 53-57.
Nicklin JL, Perrin LC, Obermair A, McConachie, A, Cominos D, : The significance of psammoma bodies on Nicklin JL, Perrin LC, Obermair A, McConachie I, Cominos D: The significance of cervical cytology smears. Gynecol Oncol 2001; 83: 6-9.
Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL, Perrin LC, Ward BG, Crandon AJ: Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 2001; 83:115-120.
Obermair A, Cheuk R, Horwood K, Janda M, Bachtiary B, Schwanzelberger B, Stoiber A, Nicklin J, Perrin L, Crandon A: Impact of Hemoglobin Levels before and during Chemo-Radiotherapy on the Response to Treatment in Patients with Cervical Carcinoma: Preliminary Results. Cancer 2001; 92: 903-908.
Umek W, Obermair A, Stutterecker D, Hausler G, Leodolter S, Hanzal E: Three-dimensional ultrasound of the fermal urethra: comparing transvaginal and transrectal scanning. Ultrasound in Obstet Gynecol 2001; 17: 425-430.
Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, Czerwenka K, Leodolter S, Kainz C, Mayerhofer K: Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 2001; 81: 160-165.
Obermair A, Koller S, Crandon AJ, Perrin L, Nicklin JL: Primary Bartholin gland carcinoma: a report of seven cases. Aust N Z J Obstet Gynaecol 2001; 41: 78-81
Obermair A, Taylor K, Janda M, Nicklin J, Crandon A, Perrin L: Primary fallopian tube cancer: the Queensland experience. Int J Gynaecol Cancer 2001; 11: 69-72.
Obermair A, Geramou M, Tripcony L, Perrin L, Nicklin J, Crandon AJ: Peritoneal cytology: impact on disease-free survival in clincal stage I endometrioid adenocarcinoma of the uterus. Cancer Lett 2001; 164: 105-110.
Obermair A, Sevelda P: Impact of secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients. Acta Obstet Gynecol Scand 2001; 80: 432-436
Janda M, Gerstner N, Obermair A, Fuerst A, Wachter S, Dieckmann K, Ptter R: Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 2000; 89: 1322-1328.
Janda M, Obermair A, Haidinger G, Waldhoer T, Vutuc C: Attitude and knowledge of Austrian women towards breast self examination. J Cancer Edu 2000; 15: 91-4.
Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, Medl M, Rosen A, Wierrani F, Neunteufel W, Frech I, Preyer O, Speiser P, Kainz C: Impact of hysteroscopy on the diseaese-free survival in clinically stage I endometrial cancer patients. Int J Gynecol Cancer 2000; 10: 275-279.
Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C, Tempfer C: Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumor Biol 2000; 21: 309-14.
Obermair A, Petru E, Windbichler G, Peters-Engl C, Graf AH, Stummvoll W, Kaider A, Kurschel S, Klbl H, Sevelda P: Pretreatment serum hemoglobin and survival in early stage epithelial ovarian cancer. Oncol Rep 2000; 7: 639-44.
Obermair A, Geramou M., Gcer F., Denison U., Graf A.H., Kapshammer E., Neunteufel W., Frech I, Kaider A., Kainz C. for the Austrian Gynecologic Oncology Study Group: Does hysteroscopy facilitate tumo rcell dissemination? Incidence of peritoneal cytology in patients with early-stage endometrial cancer following dilatation and curettage (D&C) versus hysteroscopy + D&C. Cancer 2000; 88: 139-143.
Obermair A., Geramou M., Gcer F., Denison U., Graf, AH., Kapshammer E., Medl M. Rosen A. Wierrani, F. Neunteufel W., Frech, I., Kaider A., Speiser P., Kainz C., Gerhard Breitenecker G. for the Austrian Gynecologic Oncology Study Group: Accuracy of the finding of a well differentiated tumor in endometrial cancer patients who undergo a Dilatation & Curettage with subsequent hysterectomy. Int J Gynecol Cancer 1999; 9: 383-386.
Peters-Engl C, Obermair A, Heinzl H, Buxbaum P, Sevelda P, Medl M: CA125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer. Br J Cancer 1999; 81: 662-666.
Jakesz R, Hausmanninger H, Haider K, Kubista E, Samonigg H, Gnant M, Manfreda D, Tschurtschenthaler G, Kolb R, Stierer M, Fridrik M, Mineritsch B, Steindorfer P, Mittelbck M, Steger G, and the Austrian Breast Cancer Study Group: Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer. J Clin Oncol 1999; 17: 1701-1709.
Mayerhofer K, Obermair A, Windbichler G, Petru E, Kaider A, Hefler L, Czerwenka K, Leodolter S, Kainz C: Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999; 74: 196-201
Obermair A, Speiser P, Thoma M, Kaider A, Salzer H, Dittrich C, Sevelda P: Prediction of toxicity by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatin. Int J Oncol 1998; 13: 1023-1030.
Obermair A, Handisurya A, Kaider A, Sevelda P, Klbl H, Gitsch G: The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer 1998; 83: 726-31.
Jakesz R, Samonigg H, Gnant M, Kubista E, Steindorfer P, Hausmanninger H, Sevelda P, Tschurtschenthaler B, Fridrik M, Stierer M, Kolb R, Steger G and the Austrian Breast Cancer Study Group: Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Eur J Cancer 1998; 34:66-70.
Obermair A, Binder M, Barrada M, Bancher-Todesca D, Asseryanis E, Kubista E: Onycholysis in patients treated with docetaxel. Ann Oncol 1998; 9: 230-231 (letter).
Bancher-Todesca D, Obermair A, Zeisler H, Prainsack D, Gitsch G, Reinthaller A: Management unvollstndig entfernter Lsionen nach Schlingenkonisation. Geburtshilfe und Frauenheilkunde 1997; 57: 458-462. [German]
Marth C, Windbichler G, Petru E, Dirschlmayer W, Obermair A, Czerwenka K, Mller-Holzner E, Dapunt O: Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium. Gynecol Oncol 1997; 64: 121-125.
Obermair A, Hanzal E, Schreiner-Frech I, Buxbaum P, Bancher-Todesca D, Thoma M, Kurz C, Vavra N, Gitsch G, Sevelda P: Influence of delayed diagnosis on established prognostic factors in endometrial cancer. Anticancer Ressearch 1996; 16: 947-950.
Obermair A, Kurz C, Hanzal E, Bancher-Todesca D, Thoma M, Bodisch A, Kubista E, Kyral E, Kaider A, Sevelda P, Gitsch G: The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Research 1995; 15: 2265-2270.
Obermair A, Vavra N, Kurz C, Helmer H, Sevelda P, Pehamberger K: Onycholysis in a case of high dose etoposide treatment for ovarian cancer: Gynecol Oncol 1995, 57: 436 (letter).
Sevelda P, Kurz Ch, Obermair A, Kubista E, Salzer H for the Austrian Cooperative Breast Cancer Study Group: Hormontherapie versus Chemo-Hormontherapie bei Patientinnen mit hormonrezeptorpositivem Mammakarzinom im Stadium I und II. Arch Gynecol Obstet 1993; 254: 895-897. [German]
Sevelda P, Mayerhofer K, Obermair A, Stolzlechner J, Kurz Ch: Thrombosis with paclitaxel. Lancet 1994; 343: 727 (letter).
Kurz Ch, Obermair A, Schemper M, Kubista E, Sevelda P: Beienflut Adipositas das rezidivfreie Intervall beim Mammakarzinom? Gynkol Geburtshilfliche Rundsch 1993; 33 (Suppl 1): 305-307. [German]
Ch, Salzer H, sterreichische Arbeitsgemeinschaft zur Therapie des Ovarialkarzinoms: Die Bedeutung der Platindosisintensitt in der Behandlung des epithelialen Ovarialkarzinoms. Wien Klin Wochenschr 1993; 105: 732-736. [German]
Sevelda P, Kurz Ch, Obermair A, Vavra N, Breitenecker G, Czerwenka K, Dittrich Ch, Salzer H, Oesterreichische Arbeitsgemeinschaft zur Therapie des Ovarialkarzinoms: Die Bedeutung der Platindosisintensitaet in der Behandlung des epithelialen Ovarialkarzinoma. Wien Klin Wochenschr 1993; 105:732-736 (German)
Schmid BC, Buluwela L, Liu QY, Fasching B, Tong D, Stimpfl M, Obermair A, Leodolter S, Zeillinger R: Expression of MUC1 splice variants correlates with invasive growth of breast cancer cell lines. Breast Cancer Res Treat 2002;76:211-219.
Bachtiary B, Obermair A, Dreier B, Birner P, Breitenecker G, Knocke TH, Selzer E, Potter R: Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer 2002; 102: 237-243.
Kohlberger, Muller-Klingspor, Heinzl H, Obermair A, Breitenecker G, Leodolter S: Prognostic value of laminin-5 in serous adenocarcinomas of the ovary. Anticancer Res 2002;22:3541-4.
Bachtiary B, Selzer E, Knocke TH, Poetter R, Obermair A: Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival. Cancer Lett. 2002;179:197-203.
Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S, Zeillinger R: Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res. 2002;8:2253-2259
Obermair A, Schmid BC, Packer LM, Leodolter S, Birner P, Ward BG, Crandon AJ, McGuckin MA, Zeillinger R: Expression of MUC1 splice variants in benign and malignant ovarian tumours. Int J Cancer 2002; 100: 166-171.
Csapo B, Szeles J, Helbich TH, Klarhoefer M, Balassy C, Pammer J, Obermair A: Histopathologic correlation of high resolution magnetic resonance imaging of human cervical tissue samples at 3 tesla: validation of technique. Invest Radiol 2002; 37: 381-385.
Tong D, Fabjani G, Heinze G, Obermair A, Leodolter S, Zeillinger R: Ananlysis Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients. Int J Cancer. 2001; 95: 394-397.
Obermair A, Schmid BC, Stimpfl M, Fasching B, Preyer O, Leodolter S, Crandon AJ, Zeillinger R: Novel MUC1 splice variants are expressed in cervical carcinoma. Gynecol Oncol 2001; 83: 343-347.
Schindl M, Oberhuber G, Pichlbauer EG, Obermair A, Birner P, Kelley MR: DNA Repair-Redox Enzyme Apurinic Endonuclease in Cervical Cancer: Evaluation of Redox-Control of HIF-1alpha and Prognostic Significance. Int J Oncol, 2001; 19: 799-802.
Muller-Klingspor V, Hefler L, Obermair A, Kaider A, Breitenecker S, Kohlberger P: Prognostic value of beta1-integrin (=CD29) in serous adeneocarcinoma of the ovary. Anticancer Res 2001; 21: 2185-2188.
Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P: Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Research 2001; 61:5703-5706.
Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G: Expression of hypoxia-inducivle factor 1 alpha in epithelial ovarian tumours: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001; 7: 1661-1668.
Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G: Overexpression of hypoxia-inducible factor 1 alpha is a marker for an unfavourable prognosis in early-stage cervical cancer. Cancer Res 2000; 60: 4693-4696.
Schreiber S, Ackermann J, Obermair A, Kaufmann H, Urbauer E, Aletaha K, Gisslinger H, Chott A, Huber H, Drach J: Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularization. Br J Haematol. 2000; 110: 605-609.
Obermair A, Schmid BC, Leodolter S, Zeillinger R: Messenger RNA expression of MUC1 splice variants in epithelial ovarian cancer. Austral Asian J Cancer 2000; 1: 69-75.
Stimpfl M, Schmid BC, Obermair A, Tong D, Schiebel I, Gitsch G, Leodolter S, Zeillinger R: Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood. Oncol Res 2000; 11: 367-373..
Stimpfl M, Schmid BC, Schiebel I, Tong D, Gitsch G, Leodolter S, Obermair A, Zeillinger R: Expression of mucins and cytokeratins in ovarian cancer cell lines: possible markers to detect disseminated ovarian cancer cells. Cancer Lett 1999; 145: 133-141.
Obermair A, Obruca A, Phl M, Kaider A, Vales A, Wojta J, Leodolter S, Feichtinger W: Vascular Endothelial Growth factor and its receptors in male fertility. Fertil Steril 1999; 72: 269-275.
Bancher-Todesca D, Gitsch G, Williams KE, Kohlberger P, Neunteufel W, Obermair A, Heinze G, Breitenecker G, Hacker NF: p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma. Gynecol Oncol 1998; 71: 59-63.
Reisenberger K, Egarter C, Schiebel I, Obermair A, Kiss H, Lehner R: In vitro cytokine and prostaglandin production by amnion cells in the presence of bacteria. Am J Obstet Gynecol 1997; 176: 981-984.
Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Obermair A, Kimberger O, Czerwenka K. Ki-67 and vascular endothelial growth factor expression in uterine leiomyosarcoma. Gynecol Oncol 2004;92:175-9.
Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S, Zeillinger R.Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res 2002;8:2253-9.
Bachtiary B, Selzer E, Knocke TH, Poetter R, Obermair A: Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival. Cancer Lett. 2002 May 28;179(2):197-203
Holzer G, Obermair A, Koschat M, Preyer O, Kotz R, Trieb K: Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors. Med Pediatr Oncol 2001; 36: 601-604.
Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G: Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer. 2001; 95: 29-33.
Birner P, Obermair A, Schindl M, Kowalski H, Breitenecker G, Oberhuber G: Selective immunohistochemical staining of blood and lymphatic vessel invasion in early-stage cervical cancer. Clin Cancer Res 2001; 7: 93-97.
Birner P. Schindl M, Obermair A, Plank C, Breitenecker G, Kowalski H, Oberhuber G: Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. Anticancer Res 2000; 20: 2981-2985.
Hefler L, Tempfer C, Obermair A, Frischmuth K, Sliutz G, Reinthaller A, Leodolter S, Kainz C: Serum concentrations of vascular endothelial growth factor in vulvar cancer. Clin Cancer Res 1999; 5: 2806-2809.
Obermair A, Hefler L, Nather A, Preyer O, Kaider A: Correlation of the serum concentration of vascular endothelial growth factor (VEGF) and hemoglobin levels in patients with epithelial ovarian cancer. Ann Oncol 1999; 10: 998 (letter).
Bancher-Todesca D, Rosen A, Graf A, Wasicky R, Hohlagschwandtner M, Rebhandl W, Heinze G, Breitenecker G, Gitsch G, Obermair A: Prognostic significance of tumor angiogenesis in primary fallopian tube cancer. Cancer Lett 1999; 141: 179-186.
Hefler L, Tempfer C, Kainz C, Obermair A: Serum concentrations of endostatin in patients with vulvar cancer. Gynecol Oncol 1999; 74: 151-152 (letter).
Hefler L, Obermair A, Tempfer C, van Houte M, Maenner G, Reinthaller A, Leodolter S, Kainz C: Serum concentrations of squmous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer. Int J Cancer 1999; 84: 299-303.
Obermair A, Wasicky R, Kaider A, Preyer O, Leodolter S, Klbl H: Prognostic significance of tumor angiogenesis in epithelial ovarian cancer. Cancer Lett 1999; 138: 175-182.
Obermair A, Tempfer C, Wasicky R, Kaider A, Hefler L, Kainz C: Prognostic significance of tumour angiogenesis in endometrial cancer. Obst Gynecol 1999; 93: 367-371.
Tempfer C, Obermair A, Hefler L, Husler G, Gitsch G, Kainz C: Vascular Endothelial Growth factor serum concentrations in ovarian cancer. Obstet Gynecol 1998; 92: 360-363.
Obermair A, Speiser P, Reisenberger K, Ullrich R, Czerwenka K, Kaider A, Zeillinger R, Miksche M: Influence of intratumoral basic Fibroblast Growth Factor concentration on survival in ovarian cancer patients. Cancer Lett 1998; 130: 69-76.
Obermair A, Tempfer C, Hefler L, Preyer O, Kaider A, Leodolter S, Kainz C: Concentration of Vascular Endothelial Growth Factor (VEGF) in the serum of patients with suspected ovarian cancer. Br J Cancer 1998; 77: 1870-1874.
Peters-Engl C, Medl M, Mirau M, Wanner C, Bilgi S, Sevelda P, Obermair A: Color-coded and spectral doppler flow in breast carcinomas-relationship with tumor microvasculature. Breast Cancer Res Treat 1998; 47: 83-89.
Obermair A, Wanner C, Bilgi S, Speiser P, Bancher-Todesca D, Czerwenka K, Kaider A, Reinthaller A, Leodolter S, Gitsch G: Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol 1998;178: 314-319.
Obermair A, Wanner C, Bilgi S, Speiser P, Reisenberger K, Kaider A, Kainz C, Leodolter S, Breitenecker G, Gitsch G: The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: Correlation of results from Hematoxylin and Eosin staining with results from immunostaining for Factor VIII-related antigen. Cancer 1998; 82: 689-696.
Obermair A, Bancher-Todesca D, Bilgi S, Kaider A, Kohlberger P, Mllauer-Ertl S, Leodolter S, Gitsch G: Correlation of Vascular Endothelial Growth Factor Expression and Microvessel Density in Cervical Intraepithelial Neoplasia. J Natl Cancer Inst 1997; 89, 1212-1217.
Obermair A, Kucera E, Mayerhofer K, Spesier P, Seifert M, Czerwenka K, Kaider A, Leodolter S, Kainz C, Zeillinger R: Vascular Endothelial Growth factor (VEGF) in human breast cancer: Correlation with disease-free survival. Int J Cancer 1997; 74: 455-458.
Bancher-Todesca D, Obermair A, Bilgi S, Kohlberger P, Kainz C, Breitenecker G, Leodolter S, Gitsch G: Angiogenesis in Vulvar Intraepithelial Neoplasia. Gynecol Oncol 1997; 64: 496-500.
Kohlberger P, Obermair A, Sliutz G, Heinzl H, Koelbl H, Breitenecker G, Gitsch G, Kainz C: Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma. Am J Clin Pathol 1996; 105: 705-710.
Obermair A, Kohlberger P, Bancher-Todesca D, Tempfer C, Sliutz G, Reinthaller A, Kainz C, Breitenecker G, Gitsch G: Influence of Microvessel Density and Vascular Permeability Factor/ Vascular Endothelial Growth Factor (VPF/VEGF) Expression on Prognosis in Vulvar Cancer. Gynecol Oncol 1996; 63: 204-209.
Sliutz G, Tempfer C, Obermair A, Reinthaller A, Gitsch G, Kainz C: Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Letters 1995; 94: 227-231.
Sliutz G, Tempfer C, Obermair A, Dadak C, Kainz C: Serum evaluation of basic FGF in breast cancer patients. Anticancer Research 1995; 15: 2675-2678.
Kainz C, Speiser P, Wanner C, Obermair A, Tempfer C, Sliutz G, Reinthaller A, Breitenecker G: Prognostic value of tumour microvessel density in cancer of the uterine cervix stage Ib to IIb. Anticancer Research 1995; 15: 1549-1552.
Obermair A, Kurz C, Czerwenka K, Thoma M, Kaider A, Wagner T, Gitsch G, Sevelda P: Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int J Cancer 1995; 62: 126-131.
Obermair A, Czerwenka K, Kurz Ch, Kaider A, Sevelda P: Tumorale Gefdichte bei Mammatumoren und ihr Einflu auf das rezidivfreie Intervall. Chirurg 1994; 65: 611-615. [German]
Obermair A, Czerwenka K, Kurz Ch, Kaider A, Sevelda P: Tumorgefinvasion beim Mammakarzinom: Hematoxylin-Eosin vs. Immunhistochemische Frbung gegen Faktor VIII-Antigen. Dtsch Med Woschr 1994, 119: 1491-1496.
Obermair A, Czerwenka K, Kurz Ch, Buxbaum P, Schemper M, Sevelda P: Influence of tumoral microvessel density on the recurrence-free survival in human breast cancer: Preliminary results. Onkologie 1994; 17: 44-49.
Kurz Ch, Obermair A, Nagele F, Czerwenka K, Schemper M, Kubista E, Sevelda P: Die Wertigkeit des Faktors "Gefinvasion" fr die Prognose des Mammakarzinoms. Geburtsh Frauenheilk 1994; 54: 295-299. [German]
Obermair A, Czerwenka K, Kurz Ch, Schemper M, Sevelda P: Vessel invasion predicts early recurrence in breast cancer: Preliminary results. Onkologie 1993; 16: 434-437.
Hammond I, Taylor J, Obermair A, McMenamin P. The anatomy of complications workshop: an educational strategy to improve the training and performance of fellows in gynecologic oncology. Gynecol Oncol 2004;94:769-73.
Janda M, Stanek C, Newman B, Obermair A, Trimmel M: Impact of videotaped information on frequency and confidence of breast self-examination. Breast Cancer Res Treat. 2002;73:37-43.
Umek WH, Laml T, Stutterecker D, Obermair A, Leodolter S, Hanzal E: The Urethra During Pelvic Floor Contraction: Observations on Three-Dimensional Ultrasound. Obstet Gynecol 2002; 100:796-800.
Schindl M, Birner P, Obermair A, Kiesel L, Wenzl R: Increased microvessel density in adenomyosis uteri. Fertil Steril 2001; 75: 131-135.
Hefler L, Obermair A, Husslein P, Kainz C, Tempfer C: Vascular endothelial growth factor serum levels in pregnancy and preeclampsia. Acto Obstet Gynecol Scand 2000; 79: 77-78.
Kurz C, Salzer H, Arbeiter K, Obermair A, Salzer HR, Lohninger A: L-Carnitin-Betamethason Kombinationstherapie versus alleiniger Betamethasontherapie als Prophylaxe des Atemnotsyndroms. Z Geburtsh Perinat. 1993; 197: 215-219. [German]
Aichberger L, Boldizsar B, Herczeg S, Obermair A, Plckinger B, Strohmer H, Vatanparast S, Kemeter P, Feichtinger F: Die vaginosonografische Beobachtung von Uteruskontraktionen beim Embryotransfer und ihre Relevanz im Hinblick auf den Behandlungserfolg; Geburtshilfe und Frauenheilkunde 1991; 51: 27-30. [German]
Obermair A: Die Erstellung einer gynkologisch-onkologischen Patientendatei fr die Nachsorge; Wiener Klin. Wochenschrift 1991; 103: 371-373. [German]
Seifert M, Adler A, Obermair A, Hartmann B, Denison U, Kubista E, Sevelda P: Mglichkeiten und Ziele der Tumornachsorge beim Mammakarzinom. Gynkol Geburtsh Rundsch 1991; 31: 309-311. [German]
Obermair A: Angiogenese und Prognose beim Mammakarzinom. In: Prognostische und therapierelevante Faktoren beim Mammakarzinom. Ergebnisse einer Konsensuskonferenz. S. Classen, H. Graeff, F. Jnicke, H. Sauer, W. Wilmanns (Hrsg.). Excerpta Oncologica Vol 6, pp 101-109. Novartis Pharma Verlag, Nrnberg 1997. [German]
Obermair A, Preyer O, Leodolter S: Angiogenese in Gynkologie und Geburtshilfe. Wien Klin Woschr 1999; 111: 262-277.
Obermair A, Preyer O, Leodolter S: Tumor angiogenesis and its relation to prognosis in epithelial ovarian cancer. CME Journal of Gynecologic Oncology 1999; 4: 169-177.
Obermair A, Preyer O, Bachtiary B: Angiogenesis in cervical cancer. CME Journal of Gynecologic Oncology 2001; 6:184-191.
OBERMAIR, Andreas, The Anatomy of Complications Workshop: An Educational Strategy to Improve the Training and Performance of Fellows in Gynecologic Oncology. IGCS 10, 10th Biennial International Gynaecologic Cancer Society Meeting (IGCS), Edinburgh, Scotland, October 3-7, 2004.
OBERMAIR, Andreas, Uterine Papillary Serous Carcinoma – The Need for a Trial. ASGO, 19th Annual Meeting of the Australian Society of Gynaecological Oncologists, Shangri-La's Rasa Sentosa Resort, Sentosa Island, Singapore, 12-16 May 2004.
OBERMAIR, Andreas, Prognostic Significance of Preoperative CA125 in FIGO Stage I Epithelial Ovarian Cancer – An Australian Multicentre Study. IGCS 10, 10th Biennial International Gynaecologic Cancer Society Meeting (IGCS), Edinburgh, Scotland, October 3-7, 2004.
OBERMAIR, Andreas, A New Surgical Technique to Control Major Intraoperative Bleeding in Gynaecologic Cancer patients: The Overlay Autogenous Tissue (OAT) Patch. IGCS 10, 10th Biennial International Gynaecologic Cancer Society Meeting (IGCS), Edinburgh, Scotland, October 3-7, 2004.
OBERMAIR, Andreas, Accuracy of the Current FIGO Staging System for Advanced Vulval Cancer Patterns of Recurrence and Disease-Free Survival in Advanced Carcinoma of the Vulva. IGCS 10, 10th Biennial International Gynaecologic Cancer Society Meeting (IGCS), Edinburgh, Scotland, October 3-7, 2004.
OBERMAIR, Andreas, Comparison of Total Laparoscopic Hysterectomy with Total Abdominal Hysterectomy for Endometrial Cancer – Patterns of Recurrence and Survival. The Annual Meeting on Women's Cancer, 34th Annual Meeting, Society of Gynecological Oncologists, Hilton New Orleans Riverside, New Orleans, Louisiana. Friday, January 31 – Tuesday, February 4, 2003.
OBERMAIR, Andreas, Quality of the Surgical Treatment in Ovarian Cancer Patients in Austria. 13th International Meeting of the European Society of Gynaecolgical Oncology (ESGO). Congress Palace, Brussels, Belgium, April 6 – 10, 2003.
OBERMAIR, Andreas, Total Laparoscopic Hysterectomy for the Treatment of Endometrial Cancer: Morbidity and Patterns of Recurrence. 13th International Meeting of the European Society of Gynaecolgical Oncology (ESGO). Congress Palace, Brussels, Belgium, April 6 – 10, 2003.
OBERMAIR, Andreas, Palliative Care in Gynaecologic Oncology – is There a Need to do More. 13th International Meeting of the European Society of Gynaecolgical Oncology (ESGO). Congress Palace, Brussels, Belgium, April 6 – 10, 2003.
Sevelda P, Denison U, Baumann J, Samonigg H, Krippl P, Lang A, Obermair A, Wagner H: Prevalence of anaemia in breast cancer patients receiving adjuvant chemotherapy. Breast 2001; 10 (Suppl 1): S37 (abstract #(83).
Bodner K, Bodner-Adler B, Obermair A, Petru E, Kaider A, Czerwenka K, Leodolter S, Mayerhofer K: Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Eur J Gynaecol Oncol 2001; 22 (Suppl): 88 (abstract # 222).
Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Czerwenka K, Leodolter S, Mayerhofer K: Prognostic parameters in endometrial stromal sarcoma: a clinico-pathologic study of 31 patients. Eur J Gynaecol Oncol 2001; 22 (Suppl): 71 (abstract # 173).
Obermair A, Cheuk R, Horwood K, Janda M, Bachtiary B, Schwanzelberger B, Stoiber A, Nicklin JL, Perrin LC, Crandon AJ: The impact of anaemia on the outcome of patients undergoing concurrent chemoradiation for cervical carcinoma. Eur J Gynaecol Oncol 2001; 22 (Suppl): 67 (abstract # 162).
Obermair A, Schmid BC, Stimpfl M, Fasching B, Preyer O, Leodolter S, Crandon AJ, Zeillinger R: Expression of novel MUC1 splice variants in human cervical carcinoma cell lines. Eur J Gynaecol Oncol 2001; 22 (Suppl): 57 (abstract # 134).
Obermair A, Tamandl D, Hagenauer S, Nicklin JL, Perrin LC, Ward BG, Crandon AJ: Low anterior en-bloc resection and restorativbe anastomosis in advanced stage ovarian cancer: feasibility and safety. Eur J Gynaecol Oncol 2001; 22 (Suppl): 46 (abstract # 106).
Preyer O, Bachtiary B, Obermair A: Angiogenesis in cervical carcinoma. Eur J Gynaecol Oncol 2001; 22 (Suppl): 26 (abstract # 52).
Obermair A, Cheuk R, Horwood K, Janda M, Bachtiary B, Nicklin JL, Perrin LC, Crandon AJ: Hemoglobin levels before and during chemoradiation for cervical carcinoma: impact on the response of treatment. Proc of the 32nd Annual Meeting of the Society of Gynecologic Oncologists (SGO) 2001, p 73 (abstract #51).
Obermair A, Petru E, Windbichler G, Peters-Engl C, Graf AH, Stummvoll W, Kaider A, Kurschel S, Klbl H, Sevelda P: Prognostic impact of tumor anemia in early-stage epithelial ovarian cancer. Eur J Cancer 1999; 35 (Suppl 4): 233 (abstract # 913).
Obermair A, Stimpfl M, Schmid B, Tong D, Schiebel I, Leodolter S, Zeillinger R: MUC1 mucin for the detection of epithelial derived ovarian cnacer cells in peripheral blood. Eur J Cancer 1999; 35 (Suppl 4): 107 (abstract # 374).
Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, Neunteufel W, Frech I, Kaider A, Kainz C for the Austrian Gynecologic Oncology Study Group: Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology in patients with early-stage endometrial cancer following dilatation & curettage (D&C) vs. hysteroscopy + D&C. Int. J. Gynecol Cancer 1999 (Suppl 1); 9: 92 (Abstract # B95).
Obermair A, Stimpfl M, Schmid B, Tong D, Schiebel I, Leodolter S, Zeillinger R: MUC1 mucin for the detection of epithelial derived ovarian cnacer cells in peripheral blood. Int. J. Gynecol Cancer 1999 (Suppl 1); 9: 73 (Abstract # B35).
Preyer O, Nather A, Hefler L, Tempfer C, Kaider A, Leodolter S, Obermair A: Serum concentrations of hemoglobin and vascular endothelial growth factor (VEGF) in patients with epithelial ovarian cancer. Int. J. Gynecol Cancer 1999 (Suppl 1); 9: 53 (Abstract # A162).
Umek W, Preyer O, Kratochwil A, Leodolter S, Obermair A: Erste Erfahrungen mit 3D Ultraschall und Levovist zur Darstellung von Gefen bei suspekten Adnexbefunden. Gynkol Geburtshilfliche Rundsch 1999; 39: 99 (abstrakt #152). [German]
Preyer O, Obermair A, Breitenecker G, Leodolter S, Kainz C, Dadak C: Nikotinabusus und Rezidivhufigkeit bei Patientinnen mit Condylomata acuminata. Gynkol Geburtshilfliche Rundsch 1999; 39: 88 (abstrakt #108). [German]
Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer, Neunteufel W, Frech I, Kaider A, Kainz C fr die sterreichische Arbeitsgemeinschaft Gynkologische Onkologie: Bewirkt die Hysteroskopie eine Tumorzelldissemination? Peritonealzytologie bei Endometriumkarzinom-Patientinnen mit und ohne Hysteroskopie. Gynkol Geburtshilfliche Rundsch 1999; 39: 85 (abstrakt #99). [German]
Janda M, Gerstner N, Wachter S, Obermair A, Schlappack O, Ptter R: Quality of life (QOL) and fatigue in patients receiving external beam radiation for prostate cancer: Comparison of questionaires EORTC-QLQ-C30 with Medical Outcomes Study Short Form Health Survey SF-36. Proc Am Soc Clin Oncol 1999; 18:581a (abstract#2244).
Obermair A, Petru E, Windbichler G, Peters-Engl C, Graf AH, Stummvoll W, Kaider A, Kurschel S, Klbl H, Sevelda P: Pretreatment serum hemoglobin and survival in early-stage epithelial ovarian cancer. Proc Am Soc Clin Oncol 1999; 18:381a (abstract#1473).
Obermair A, Stimpfl M, Schmid B, Tong D, Schiebel I, Leodolter S, Zeillinger R: MUC1 mucin for the detection of epithelial-derived ovarian cancer cells in peripheral blood. Eur J Gynecol Oncol 1999; 20:124 (abstract #277).
Preyer O, Hefler L, Tempfer C, Wasicky R, Kaider A, Leodolter S, Obermair A: Vascular endothelial growth factor (VEGF) in epithelial ovarian cancer. Eur J Gynecol Oncol 1999; 20:85 (abstract #188).
Obermair A, Petru E, Windbichler G, Peters-Engl C, Graf AH, Stummvoll W, Kaider A, Kurschel S, Klbl H, Sevelda P: Pretreatment serum hemoglobin and survival in early-stage epithelial ovarian cancer. Eur J Gynecol Oncol 1999; 20:74 (abstract #154).
Obermair A, Geramou M, Gcer F, Denison U, Graf AH, Kapshammer E, Neunteufel W, Frech I, Kaider A, Kainz C: Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology in patients with early-stage endometrial cancer following dilatation & curettage vs. hysteroscopy plus dilatation & curettage. Eur J Gynecol Oncol 1999; 20:53 (abstract #106).
Hefler L, Obermair A, Tempfer C, Reinthaller A, Leodolter S, Kainz C: Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer. Eur J Gynecol Oncol 1999; 20:36 (abstract #68).
Mayerhofer K, Obermair A, Petru E, Windbichler G, Czerwenka K, Kaider A, Kainz C, Klbl H, Leodolter S: Uterus Leiomyosarkom: Klinisch-pathologische Ergebnisse einer multizentrischen, retrospektiven Studie von 71 Fllen. Arch Gynecol Obstet 1998 (Suppl 1); 261: 128 (abstract # P2.14.17). [German]
Bancher-Todesca D, Obermair A, Kohlberger P, Breitenecker G, Gitsch G: P53 - ein Prognosefaktor bei sers-papillrem Endometriumkarzinom. Arch Gynecol Obstet 1998 (Suppl 1); 261: 126 (abstract # P2.14.11). [German]
Obermair A, Geramou M, Denison U, Wierrani F, Rosen A, Graf A, Nather A, Petru E, Kainz C: Hysteroskopie beim Endometriumkarzinom. Arch Gynecol Obstet 1998 (Suppl 1); 261: 124 (abstract # P2.14.02). [German]
Obermair A, Wanner C, Bilgi S, Speiser P, Kaider A, Reinthaller A, Leodolter S, Gitsch G: Prognostic impact of microvessel density in stage IB carcinoma of the uterine cervix. Ann Oncol 1998 (Suppl 2); 9:78 (abstract #297).
Obermair A, Speiser P, Ullrich R, Czerwenka K, Kaider A, Zeillinger R, Miksche M, Kainz C: Effect of intratumoral fibroblast growth factor-basic on ovarian cancer patients' survival. Int J Gynecol Cancer 1997;7 (Suppl 2): 69 (abstract P148).
Obermair A, Wanner C, Bilgi S, Bancher-Todesca D, Kainz C, Gitsch G: Vessel invasion in carcinoma of the uterine cervix: lymphatic versus blood vessel invasion. Int J Gynecol Cancer 1997;7 (Suppl 2): 32 (abstract P002).
Thoma M, Obermair A, Speiser P, Kaider A, Salzer H, Dittrich C, Sevelda P: Prediction of toxicity by determining carboplatin exposure in epithelial ovarian cancer patients treated with a combination of carboplatin and cisplatin. Int J Gynecol Cancer 1997;7 (Suppl 2): 65 (abstract P132).
Janda M, Obermair A, Handisurya A, Wasicky R, Kaider A, Sevelda P, Koelbl H, Ford P: Prognostic impact of tumor anemia in patients with epithelial ovarian cancer. Proc Am Soc Clin Oncol 1997; 16: 372a (abstract #1324).
Kohlberger P, Mian C, Wiener H, Obermair A, Bancher D, Kainz C, Gitsch G, Breitenecker G (Spon: Kieback D.): Numerical chromosomal aberrations in borderline, benign and malignant surface epithelial-stromal tumors of the ovary: correlation with established prognostic factors, DNA-ploidy, p53 protein overexpression and Ki-67. J Soc Gynecol Invest 1997; 4: 171 (suppl) (abstract # 367).
Obermair A, Handisurya A, Bancher-Todesca D, Breitenecker G, Klbl H, Sevelda P, Gitsch G: Prognostic significance of pretreatment hemoglobin in epithelial ovarian cancer: preliminary results. Europ J Gynecol Oncol 1997; 18: 270 (abstract # 152).
Obermair A, Wanner C, Bancer-Todesca D, Kohlberger P, Bilgi S, Breitenecker G, Leodolter S, Gitsch G: Tumor-angiogenesis in cervical intraepithelial neoplasia (CIN) and in invasive carcinoma of the uterine cervix (clinical stage IB). Europ J Gynecol Oncol 1997; 18: 231 (abstract #44).
Gitsch G, Wanner C, Bilgi S, Bancher-Todesca D, Kaider A, Obermair A: Vessel invasion in cervical cancer: lymphatic (LVI) versus blood vessel invasion (BVI). Europ J Gynecol Oncol 1997; 18: 229-230 (abstract # 40).
Bancher-Todesca D, Obermair A, Bilgi S, Kohlberger P, Kainz C, Breitenecker G, Leodolter S, Gitsch G: Angiogenesis in vulvar intraepithelial neoplasia (VIN) and in vulvar cancer. Europ J Gynecol Oncol 1997; 18: 224 (abstract # 24). [German]
Obermair A, Bancher-Todesca D, Bilgi S, Gitsch G: Tumorangiogenese bei der zervikalen intraepithelialen Neoplasie. Arch Gynecol Obstet 1996; 258: 171 (suppl 1) (abstract # V3.GS.09). [German]
Kohlberger P, Obermair A, Sliutz G, Heinzl H, Koelbl H, Gitsch G, Kainz C, Breitenecker G: Immunhistochemische Faktor VIII bestimmung beim Mammakarzinom: Vergleich computersuntersttzte Bildanalyse mit herkmmlichen Zhlmethoden. Verh Dtsch Ges Path 1996; 80: 606 (abstract). [German]
Obermair A, Kohlberger P, Sliutz G, Bancher-Todesca D, Tempfer C, Kainz C, Reinthaller A, Breitenecker G, Gitsch G: Die prognostische Bedeutung der Tumor-Angiogenese beim Vulvakarzinom. Ber Pathol 1996; 123: 3 (abstract). [German
Dittrich C, Obermair A, Kurz C, Vavra N, Speiser P, Breitenecker G, Salzer H, Sevelda P for the Austrian Ovarian Cancer Study Group: Prospective randomized trial of Cisplatin/Carboplatin versus conventional Cisplatin/Cyclophosphamide in epithelial ovarian cancer: first results of the impact of platinum dose intensity on patient outcome. Proc Am Soc Clin Oncol 1996; 15: 279 (abstract).
Joura EA, Obermair A, Lsch A, Sam C, Bancher-Todesca D, Joura EM, Breitenecker G, Gitsch G: Histopathological Prognostic Factors in Infiltrating Ductal Carcinoma of the Breast. Anticancer Research 1995; 15: 1829-1830 (abstract).
Obermair A, Bancher-Todesca D, Bodisch A, Thoma M, Joura EA, Kurz C, Wagner T, Kaider A, Sevelda P, Gitsch G: Angiogenesis Parameters, as Microvessel Density and Vessel Invasion, rather than Established Prognostic Factors influence Breast Cancer Prognosis. Anticancer Research 1995; 15: 1826 (abstract).
Obermair A, Bancher-Todesca D, Bodisch A, Thoma M, Speiser P, Zeilinger R, Kaider A, Miksche M, Sevelda P, Gitsch G: Intratumoral Basic Fibroblast Growth Factor Level influences the Outcome in Patients with Epithelial Ovarian Cancer. Anticancer Research 1995; 15: 1768 (abstract).
Obermair A, Bancher-Todesca D, Bodisch A, Thoma M, Kaider A, Salzer H, Dittrich C, Gitsch G, Sevelda P: Impact of area-under-the-curve of carboplatin on response rate and overall survival in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatin. Anticancer Research 1995; 15: 1769-1770 (abstract).
Bancher-Todesca D, Obermair A, Kurz C, Hanzal E, Bodisch A, Thoma M, Kubista E, Kaider A, Sevelda P, Gitsch G: Obesity does not influence the disease-free survival in patients with primary breast cancer. Anticancer Research 1995; 15: 1831-1832 (abstract).
Joura EA, Bancher-Todesca D, Lsch A, Zeisler H, Obermair A, Breitenecker G, Gitsch G: Vulvar Intraepithelial Neoplasia (VIN): Diagnosis value of non-invasive methods. Anticancer Research 1995; 15: 1817 (abstract).
Bancher-Todesca D, Obermair A, Hanzal E, Bodisch A, Thoma M, Vavra N, Sevelda P, Gitsch G: Delayed diagnosis of endometrial cancer in patients with abnormal postmenopausal bleeding. Anticancer Research 1995; 15: 1817 (abstract).
Bancher-Todesca D, Zeisler H, Obermair A, Joura EA, Bodisch A, Thoma M, Kainz C, Breitenecker G, Reinthaller A, Gitsch G: Sarcoma Botryoides ( Embryonal Rhabdomyosarcoma) of the uterine cervix. Case report and current managment. Anticancer Research 1995; 15: 1719-1720 (abstract).
Obermair A, Kurz, C Seiser P, Czerwenka K, Kaider A, Sevelda P: Microvessel density (MVD) and blood and lymphatic vessel invasion (BLVI) in node-negative breast cancer: effect on recurrence-free survival. Anti Cancer Drugs 1995: 6 (Suppl 2): 58 (abstract # P17).
Dittrich C, Kurz C, Obermair A, Speiser P, Breitenecker G, Salzer H, Sevelda P: Prospective randomized comparison of Toxicity and dose intensity (DI) of Cisplatin (P)/Cyclophosphamide (CYC) with intensified platin of P/Carboplatin in ovarian cancer. Ann Oncol 1994, 5 (Suppl 8): 99 (abstract # O 496).
Denison U, Salzer H, Obermair A, Keil M, Kurz C, Vavra N, Sevelda P: Das Mammakarzinom der Frau unter 35 Jahren. Gynkol Geburtsh Rundsch 1994; 34 (Suppl 1): 141-142. [German]
Buxbaum P, Obermair A, Schreiner-Frech I, Kurz C, Vavra N, Sevelda P: Verzgerte Diagnosestellung beim fortgeschrittenen Endometriumkarzinom. Gynkol Geburtsh Rundsch 1994; 34 (Suppl 1): 154-155. [German]
Obermair A, Czerwenka K, Kurz C, Schemper M, Kubista E, Sevelda P: Tumorgefinvasion und Frhrezidiv beim Mammakarzinom. Acta Chirurgica Austriaca 1993; 25 (Suppl): 103. [German]
Sevelda P, Kurz C, Obermair A, Vavra N, Breitenecker G, Salzer H, Dittrich C: Prospectively randomized trial of conventional high dose Cisplatin plus Cyclophosphamide versus Cisplatin plus Carboplatin as adjuvant therapy in epithelial ovarian cancer patients: First analysis of toxicity and dose intensity. Int J Gyn Cancer 1993; 3 (Suppl 1): 68.
Sevelda P, Kurz C, Obermair A, Kubista E, Salzer H for the Austrian Cooperative Breast Cancer Study Group: Hormontherapie vs. Chemo-Hormontherapie bei Patientinnen mit Hormonrezeptor positivem Mammakarzinom im Stadium I und II. Deutsche Gesellschaft fr Gynkologie und Geburtshilfe 49. Kongress; 9.-12.September 1992, Berlin. (abstract). [German]
Kurz C, Sevelda P, Scholten C, Kreiner M, Obermair A, Seifert M, Czerwenka K, Kubista E: Die Bedeutung der primr vollstndigen Tumorentfernung fr den weiteren Krankheitsverlauf beim Mammakarzinom. Gynkol Geburtsh Rundsch 1992; 32 (Suppl 1): 108-109. [German]
Obermair A, Seifert M, Adler A, Kubista E: A Personal Computer Based Data Bank System for the Follow-Up of Breast Cancer Patients. J Cancer Res Clin Onc 1992; 118: R47 (abstract).
Seifert M, Adler A, Obermair A, Denison U, Kubista E, Sevelda P: Possibilities, advantages and disadvantages of follow-up in breast cancer. Int. J. Gynecol. Obst. 1991; XIII World Congress of Gynaecology and Obstetrics (FIGO) (abstract # 2); 190.
|
